Elanco Animal Health (ELAN) Peer Comparison
$23.55
$-0.42
(-1.75%)
As on 09-Sep-2026 16:04EDT
Market cap
$12,237 Mln
Revenue (TTM)
$5,020 Mln
P/E Ratio
--
P/B Ratio
1.9
Div. Yield
0 %
Edit
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
12,237 | 14,631 | 12,066 | 10,826 | 10,021 |
Revenue ($ Mln) |
5,020 | 692 | 831 | 777 | 332,834 |
Net Profit ($ Mln) |
-199.00 | -696.24 | 54.90 | -191.64 | 33,166.55 |
Net Margin (%) |
-3.96 | -100.64 | 6.61 | -24.68 | 9.96 |
RoE (%) |
-3.03 | -- | 8.11 | -223.36 | 8.88 |
Price to Earnings |
-- | -- | 248.04 | -- | 29.34 |
Price-To-Book |
1.86 | 123.68 | 17.29 | 131.04 | 2.52 |
Income Statement ($ Mln)
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Operating Revenue
|
5,020.00 | 691.84 | 830.81 | 776.57 | 332,834.17 |
|
Cost of Revenue
|
2,380.00 | 47.45 | 14.09 | 52.53 | 165,910.29 |
|
Gross Profit
|
2,050.00 | 473.81 | 748.43 | 591.02 | 190,428.00 |
|
Operating Expenses
|
2,178.00 | 1,187.86 | 810.32 | 912.58 | 131,728.10 |
|
Operating Profit (EBIT)
|
462.00 | -543.47 | 6.41 | -188.54 | 35,195.77 |
|
Other Income
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Profit before Tax
|
-166.00 | -706.17 | 26.37 | -191.09 | 41,359.76 |
|
Provision for Tax
|
33.00 | -7.73 | -35.26 | 0.56 | 8,582.66 |
|
Profit after Tax (Net Income)
|
-199.00 | -696.24 | 54.90 | -191.64 | 33,166.55 |
|
Minority Interest
|
0.00 | 10.15 | 0.00 | 0.00 | 389.00 |
|
Consolidated Profit
|
0.00 | 0.00 | 0.00 | 0.00 | 25,570.00 |
Liabilities ($ Mln)
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
6,588.00 | -2,515.22 | 705.78 | 83.30 | 383,428.00 |
|
Minority Interest
|
0.00 | 10.15 | 0.00 | 0.00 | 389.00 |
|
Non-Current Liabilities
|
5,121.00 | 2,832.54 | 29.12 | 217.70 | 31,229.00 |
|
Current Liabilities
|
1,852.00 | 890.65 | 153.80 | 460.45 | 157,341.00 |
|
Total Liabilities
|
13,358.00 | 936.03 | 836.65 | 689.81 | 492,989.00 |
Assets ($ Mln)
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
9,764.00 | 124.16 | 449.03 | 104.88 | 275,974.00 |
|
Current Assets
|
3,797.00 | 1,093.14 | 439.68 | 656.57 | 299,331.00 |
|
Total Assets
|
13,358.00 | 936.03 | 836.65 | 689.81 | 492,989.00 |
|
Total Debt*
|
3,918.00 | 2,493.78 | 9.42 | 219.21 | 71,952.00 |
|
Net Current Assets
|
1,945.00 | 202.49 | 285.87 | 196.12 | 141,990.00 |
Cashflow ($ Mln)
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
560.00 | -445.91 | 142.00 | -93.41 | 46,428.00 |
|
Cash Flow from Investing Activities
|
-279.00 | -24.49 | 69.76 | -0.48 | -58,077.00 |
|
Cash from Financing Activities
|
-275.00 | 359.29 | -220.37 | 101.47 | 18,911.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-2.21 | -159.44 | 14.87 | -63.21 | 16.61 |
|
ROE (%)
|
-3.03 | 41.15 | 8.11 | -223.36 | 8.88 |
|
ROA (%)
|
-1.30 | -41.39 | 5.52 | -17.39 | 4.76 |
|
EBIT Margin (%)
|
1.61 | -89.09 | 3.17 | -17.57 | 11.08 |
|
Net Margin (%)
|
-3.96 | -100.64 | 6.61 | -24.68 | 9.96 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
11.95 | 193.38 | 16.02 | 56.87 | -0.43 |
|
EBIT Growth (%)
|
-90.61 | 5.05 | -79.11 | 42.45 | -53.96 |
|
Net Profit Growth (%)
|
-145.85 | 10.33 | -58.66 | 22.38 | -41.61 |
|
EPS Growth (%)
|
-146.42 | 12.58 | -62.44 | 25.75 | -41.56 |
|
Book Value Growth (%)
|
-3.87 | -36.90 | 12.98 | 9.44 | 9.58 |
Valuation Ratios
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-48.47 | -20.69 | 41.86 | -50.48 | 0.19 |
|
Price / Book Value
|
1.72 | -7.27 | 6.44 | 104.73 | 0.03 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
21.77 | -25.60 | 55.67 | -54.53 | 0.00 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.58 | -0.77 | 0.00 | 1.42 | 0.00 |
|
Short term debt to equity ratio
|
0.01 | -0.22 | 0.00 | 0.85 | 0.16 |
|
Current Ratio
|
2.05 | 1.23 | 2.86 | 1.43 | 1.90 |
|
Quick Ratio
|
1.10 | 1.17 | 2.77 | 1.34 | 1.39 |
|
Interest Coverage
|
0.36 | -6.86 | -- | -37.09 | 10.86 |
Operating Efficiency Ratios
| Elanco Animal Health (ELAN) | BridgeBio Pharma (BBIO) | Corcept Therapeutics (CORT) | Axsome Therapeutics (AXSM) | Dr. Reddy's Laboratories - ADR | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
22.95 | 36.78 | 9.26 | 35.73 | 37.38 |
|
Asset Turnover
|
0.33 | 0.41 | 0.84 | 0.70 | 0.48 |
|
Receivable days
|
70.73 | 52.44 | 28.27 | 104.82 | 115.08 |
|
Inventory Days
|
226.89 | 172.81 | 355.76 | 167.98 | 181.99 |
|
Payable days
|
45.50 | 296.14 | 785.55 | 529.03 | 56.23 |
|
Cash Conversion Cycle
|
252.12 | -70.89 | -401.52 | -256.23 | 240.84 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
